Levalbuterol Solution
Product Images NDC 50090-6377

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 50090-6377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906377)

Levalbuterol 0.63 mg/3 mL respiratory inhalation solution by A-S Medication Solutions. The label indicates the product contains levalbuterol hydrochloride at 0.63 mg per 3 mL dose (0.021%). Packaging includes 25 sterile unit-dose vials of 3 mL each. Storage instructions specify protecting from light and keeping at 68 to 77 degrees Fahrenheit.*

FDA Label Image

Chem Structure (Levalbuterol Inhalation Solution 1)

Chemical structure of Levalbuterol Hydrochloride, showing its molecular components including hydroxyl groups, aromatic ring, and hydrochloride moiety for the inhalation solution form.*

FDA Label Image

Figure D (Levalbuterol Inhalation Solution 10)

An instructional illustration showing a hand holding a vial positioned above a labeled reservoir, indicating the vial contents are to be added or connected to the reservoir component, likely part of an inhalation device assembly procedure.*

FDA Label Image

Figure E1 (Levalbuterol Inhalation Solution 11)

An instructional illustration showing components of a respiratory inhalation device for Levalbuterol solution. It labels the detachable mouthpiece and the reservoir chamber attached to the main body of the inhaler device.*

FDA Label Image

Figure E2 (Levalbuterol Inhalation Solution 12)

An instructional illustration showing a face mask connected to a reservoir, likely part of a respiratory inhalation device setup for administering medication.*

FDA Label Image

Figure F (Levalbuterol Inhalation Solution 13)

A black and white line illustration depicting a medical device labeled as a 'COMPRESSOR' with an attached 'NEBULIZER TUBING.' The image shows the tubing connected to the compressor, likely representing part of a respiratory inhalation system.*

FDA Label Image

Figure G1 (Levalbuterol Inhalation Solution 14)

An instructional diagram showing a person using a respiratory inhalation device. The illustration labels the mouthpiece where the person places their lips and the reservoir holding the medication solution.*

FDA Label Image

Figure G2 (Levalbuterol Inhalation Solution 15)

An instructional illustration showing the correct positioning of a face mask and reservoir attached to an inhalation device, likely demonstrating usage for a respiratory solution such as Levalbuterol Hydrochloride inhalation solution.*

FDA Label Image

Logo (Levalbuterol Inhalation Solution 16)

FDA Label Image

Figure 1 (Levalbuterol Inhalation Solution 2)

A line graph depicting mean change in FEV1 (%) over time (hours) for four treatment groups labeled Lev 1.25, Lev 0.63, Rac 2.5, and PBO. The graph shows time from 0 to 8 hours on the x-axis and mean change in FEV1 (%) on the y-axis, highlighting differences in lung function response among the groups over the time course.*

FDA Label Image

Figure 2 (Levalbuterol Inhalation Solution 3)

A line graph showing the mean change in FEV1 (%) over 8 hours for four groups: Lev 1.25 mg, Lev 0.63 mg, Rac 2.5 mg, and PBO, with sample sizes indicated. The x-axis represents time in hours, and the y-axis represents mean change in FEV1 percentage. Each group shows a different time-dependent response pattern, with Lev 1.25 mg having the highest peak change.*

FDA Label Image

Figure 3 (Levalbuterol Inhalation Solution 4)

A line graph showing mean change in FEV1 (%) over 4 hours for several groups: Lev 0.63 mg, Lev 0.31 mg, Rac 2.5 mg, Rac 1.25 mg, and Pbo. The x-axis represents time in hours (0 to 4), and the y-axis shows mean change in FEV1 percentage (-5 to 30%). Each group is represented by different markers with corresponding sample sizes indicated in the legend. The graph includes a dashed reference line at 15% change.*

FDA Label Image

Figure 4 (Levalbuterol Inhalation Solution 5)

A line graph showing mean change in FEV1 (%) over time (hours) comparing responses to Levalbuterol at 0.63 mg and 0.31 mg, Racemic albuterol at 2.5 mg and 1.25 mg, and placebo. The graph includes data points for each treatment group with a reference line at 15% change.*

FDA Label Image

Logo (Levalbuterol Inhalation Solution 6)

FDA Label Image

Figure A (Levalbuterol Inhalation Solution 7)

An instructional diagram illustrating the twist-off tab portion of a vial. The image shows the top of the vial with clear arrows indicating where to twist off the tab for opening. The shaded area highlights the specific twist-off section of the vial.*

FDA Label Image

Figure B (Levalbuterol Inhalation Solution 8)

An instructional diagram showing the top portion of a sealed bag with an arrow pointing to a perforated seam and the text 'TEAR AT SEAM,' indicating where to open the packaging.*

FDA Label Image

Figure C (Levalbuterol Inhalation Solution 9)

An instructional illustration showing a hand twisting the top off a vial or ampule, likely demonstrating how to open a single-dose inhalation solution vial for Levalbuterol Hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.